These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 13576705)

  • 41. [Comparative efficiency of conventional myelosuppressive chemotherapy and therapy including interferon alpha in patients with chronic myeloid leukemia].
    Volkova SA; Prytkova MV; Borovkov NN
    Klin Med (Mosk); 2004; 82(3):45-50. PubMed ID: 15114775
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bone marrow aplasia consecutive to myleran therapy of chronic myeloid leukemia].
    KHURGIN MI; KHASANOVA RI
    Probl Gematol Pereliv Krovi; 1959 Jan; 4(1):52-3. PubMed ID: 13645532
    [No Abstract]   [Full Text] [Related]  

  • 43. [Total bone marrow aplasia caused by uncontrolled treatment with dimethanesulfonoxybutane in a case of chronic myelocytic leukemia].
    PAOLINO W; BACHI C
    Minerva Med; 1960 Oct; 51():3450-3. PubMed ID: 13732563
    [No Abstract]   [Full Text] [Related]  

  • 44. [Data on an unusual acute transformation in a case of chronic myeloid leukemia following dimethylsulfonoxy-butane therapy].
    GIGANTE D
    Clin Ter; 1958 May; 14(5):469-85. PubMed ID: 13561522
    [No Abstract]   [Full Text] [Related]  

  • 45. Chronic granulocytic leukemia with lymphadenopathy and leukemia cutis.
    Padmanabhan K; Subramanian R; Vaidyanathan CV
    J Assoc Physicians India; 1982 Aug; 30(8):552-4. PubMed ID: 6963267
    [No Abstract]   [Full Text] [Related]  

  • 46. [Experiences with sulfabutin in the therapy of chronic myelosis].
    PLATZER S
    Med Klin; 1960 Sep; 55():1683-5. PubMed ID: 13736288
    [No Abstract]   [Full Text] [Related]  

  • 47. [Complications during chemotherapy of chronic myeloleukemia].
    MIKHAILOVA NS; RYBKIN IN
    Klin Med (Mosk); 1957 Dec; 35(12):112-5. PubMed ID: 13540084
    [No Abstract]   [Full Text] [Related]  

  • 48. Succinic dehydrogenase activity in chronic myeloid leukemia.
    Desai AJ; De Souza EJ
    Indian J Cancer; 1967 Sep; 4(3):285-7. PubMed ID: 5241768
    [No Abstract]   [Full Text] [Related]  

  • 49. Cardiac involvement in chronic myeloid leukaemia: rapid recovery with treatment.
    Gupta RR; Ghalaut PS
    Indian Heart J; 1983; 35(6):363-5. PubMed ID: 6230307
    [No Abstract]   [Full Text] [Related]  

  • 50. Comparison of BAVC to BuCy regimens in autologous stem cell transplantation for adult patients with acute myeloid leukemia.
    Fouillard L; Labopin M; Meloni G; Polge E; Gorin NC; Frassoni F
    Haematologica; 2004 Jan; 89(1):107-8. PubMed ID: 14754615
    [No Abstract]   [Full Text] [Related]  

  • 51. [Notes on a case of acute myeloleukosis treated with cortisone].
    HERISAN S; GORESCU I; MARIN-MOSCOVICI I
    Med Interna (Bucur); 1956 Nov; 8(7):1078-83. PubMed ID: 13418068
    [No Abstract]   [Full Text] [Related]  

  • 52. Risk assessment in haematopoietic stem cell transplantation: conditioning.
    Aschan J
    Best Pract Res Clin Haematol; 2007 Jun; 20(2):295-310. PubMed ID: 17448963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the mechanism of action of myleran.
    WINKLER A; UJHAZY V; CERNY V
    Neoplasma; 1957; 4(4):340-4. PubMed ID: 13504380
    [No Abstract]   [Full Text] [Related]  

  • 54. Busulfan lung: cytologic diagnosis.
    Dalri P; Piscioli F; Detassis C
    Haematologica; 1980 Aug; 65(4):469-74. PubMed ID: 6774919
    [No Abstract]   [Full Text] [Related]  

  • 55. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
    Martino R; Pérez-Simón JA; Moreno E; Queraltó JM; Caballero D; Mateos M; Sureda A; Cañizo C; Brunet S; Briones J; Vazquez L; Clopés A; San Miguel JF; Sierra J
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):437-47. PubMed ID: 15931632
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Chemotherapy of leukemic myelosis with 1,4-dimethylsulfonoxybutane (myeleukon)].
    HAMBSCH K; HAMMER O
    Dtsch Gesundheitsw; 1960 Jul; 15():1551-6. PubMed ID: 13710967
    [No Abstract]   [Full Text] [Related]  

  • 57. [Treatment of polycythemia with myelosan under ambulatory conditions].
    Krasiukova LI
    Probl Gematol Pereliv Krovi; 1975 May; 20(5):37-40. PubMed ID: 1144332
    [No Abstract]   [Full Text] [Related]  

  • 58. Myelogenous leukemia: current practice.
    Ogada T
    East Afr Med J; 1980 Jan; 57(1):5-6. PubMed ID: 6929249
    [No Abstract]   [Full Text] [Related]  

  • 59. [The onset of chronic myeloid leukosis].
    BOUSSER J; CHRISTOL D; OUTZEKOVSKY G
    Nouv Rev Fr Hematol; 1962; 2():358-69. PubMed ID: 14014526
    [No Abstract]   [Full Text] [Related]  

  • 60. [Treatment of the chronic myeloid leukemia].
    BOCK HE; GROSS R
    Arztl Wochensch; 1954 Apr; 9(15-16):344-5. PubMed ID: 13158198
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.